HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tao Jiang Selected Research

Tyrosine Kinase Inhibitors

8/2020The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer.
11/2019EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases.
11/2019Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice.
1/2019Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.
1/2019Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer.
1/2019Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M.
1/2019Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
11/2018Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
7/2018A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group.
1/2018Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tao Jiang Research Topics

Disease

451Neoplasms (Cancer)
12/2022 - 11/2002
195Glioma (Gliomas)
10/2022 - 09/2005
76Glioblastoma (Glioblastoma Multiforme)
08/2021 - 07/2008
71Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 04/2003
67Neoplasm Metastasis (Metastasis)
12/2022 - 11/2002
47Inflammation (Inflammations)
02/2022 - 09/2006
47Infections
01/2022 - 02/2005
41Carcinogenesis
12/2021 - 09/2009
37Lung Neoplasms (Lung Cancer)
06/2022 - 01/2009
27Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 08/2010
24Breast Neoplasms (Breast Cancer)
02/2022 - 06/2009
24Colonic Neoplasms (Colon Cancer)
12/2021 - 05/2010
23Stomach Neoplasms (Stomach Cancer)
03/2022 - 06/2010
21Wounds and Injuries (Trauma)
03/2022 - 02/2006
21Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2005
18Hepatocellular Carcinoma (Hepatoma)
04/2022 - 01/2012
18Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2004
17Fibrosis (Cirrhosis)
12/2021 - 05/2004
16Brain Neoplasms (Brain Tumor)
02/2022 - 08/2013
15Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 12/2006
14Diabetic Nephropathies (Diabetic Nephropathy)
09/2022 - 08/2005
14Pain (Aches)
12/2021 - 02/2011
13Carcinoma (Carcinomatosis)
02/2022 - 06/2005
13Sepsis (Septicemia)
12/2021 - 03/2006
12Adenocarcinoma of Lung
06/2022 - 09/2009
12Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 04/2005
12Lymphatic Metastasis
05/2019 - 11/2002
11Acute Lung Injury
10/2022 - 03/2010
11Esophageal Neoplasms (Esophageal Cancer)
07/2022 - 01/2010
11Human Influenza (Influenza)
01/2021 - 06/2010
11Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020 - 11/2005
11Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 09/2008
10Epilepsy (Aura)
10/2022 - 11/2006
10Obesity
07/2022 - 09/2005
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2022 - 11/2002
10Brain Ischemia (Cerebral Ischemia)
05/2022 - 04/2003
10Pathologic Constriction (Stenosis)
01/2022 - 09/2004
10Astrocytoma (Pilocytic Astrocytoma)
12/2021 - 12/2011
10Adenocarcinoma
10/2021 - 11/2005
10Hypoxia (Hypoxemia)
01/2021 - 06/2007
10Disease Progression
10/2020 - 01/2011
10Proteinuria
01/2018 - 08/2005
9Cognitive Dysfunction
11/2022 - 12/2019
9Insulin Resistance
09/2022 - 06/2005
9Hemorrhage
05/2022 - 03/2010
9Body Weight (Weight, Body)
01/2022 - 11/2007
9Reperfusion Injury
10/2021 - 03/2014
9Necrosis
10/2021 - 05/2010
9Alzheimer Disease (Alzheimer's Disease)
03/2021 - 12/2009
9Osteoarthritis
06/2020 - 04/2005
9Ischemia
01/2020 - 04/2003

Drug/Important Bio-Agent (IBA)

128Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2003
110Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2009
71MicroRNAs (MicroRNA)IBA
04/2022 - 07/2010
70Biological ProductsIBA
07/2022 - 09/2005
67Messenger RNA (mRNA)IBA
01/2022 - 07/2004
43RNA (Ribonucleic Acid)IBA
01/2022 - 01/2002
40CytokinesIBA
02/2022 - 05/2004
35Pharmaceutical PreparationsIBA
10/2022 - 05/2004
35ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2013
32Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
29Temozolomide (Temodar)FDA LinkGeneric
02/2022 - 07/2008
25Long Noncoding RNAIBA
12/2021 - 12/2013
23Therapeutic UsesIBA
03/2022 - 06/2005
23Indicators and Reagents (Reagents)IBA
11/2021 - 06/2013
23CateninsIBA
08/2021 - 09/2010
22LigandsIBA
07/2022 - 12/2009
22Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 01/2014
22Small Interfering RNA (siRNA)IBA
12/2020 - 08/2009
22Tyrosine Kinase InhibitorsIBA
08/2020 - 02/2011
21DNA (Deoxyribonucleic Acid)IBA
04/2022 - 11/2005
21VaccinesIBA
12/2021 - 11/2010
20Glucose (Dextrose)FDA LinkGeneric
09/2022 - 05/2005
20Phosphotransferases (Kinase)IBA
12/2021 - 05/2009
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 11/2002
18LipidsIBA
12/2021 - 06/2005
17EnzymesIBA
01/2022 - 06/2005
14AntigensIBA
07/2022 - 11/2007
14AntibodiesIBA
06/2022 - 11/2008
13Transcription Factors (Transcription Factor)IBA
01/2021 - 09/2004
13Matrix Metalloproteinases (MMPs)IBA
01/2020 - 12/2004
12LipopolysaccharidesIBA
10/2022 - 03/2010
12Peptides (Polypeptides)IBA
12/2021 - 12/2004
11MethyltransferasesIBA
06/2022 - 09/2010
11Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2007
11Cisplatin (Platino)FDA LinkGeneric
11/2021 - 01/2011
10Amino AcidsFDA Link
10/2022 - 04/2012
10AntioxidantsIBA
12/2021 - 01/2006
10Antiviral Agents (Antivirals)IBA
12/2021 - 02/2005
10CholesterolIBA
04/2021 - 08/2005
9Circular RNAIBA
06/2022 - 06/2020
9Cell-Penetrating PeptidesIBA
12/2021 - 12/2004
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 10/2013

Therapy/Procedure

165Therapeutics
12/2022 - 02/2007
79Drug Therapy (Chemotherapy)
07/2022 - 07/2004
41Immunotherapy
07/2022 - 08/2010
34Radiotherapy
03/2022 - 07/2008
14Transplantation
11/2020 - 07/2011
9Electroacupuncture
05/2021 - 07/2014
9Aftercare (After-Treatment)
12/2020 - 02/2011